What is the most recent earnings date for SXTP stock?
60 DEGREES PHARMA INC (SXTP) last reported earnings on 11/13/2025.
60 DEGREES PHARMA INC (SXTP) Earnings History & Surprises
NASDAQ:SXTP • US83006G5009
Current stock price
1.86 USD
-0.01 (-0.53%)
At close:
1.7615 USD
-0.1 (-5.3%)
After Hours:
SXTP Earnings overview
Past quarterly earnings results for 60 DEGREES PHARMA INC (SXTP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q4 / 2025
- EPS Estimate
- -$2.33
- Revenue Estimate
- 545.7K
Last Reported
Most Recent- Release Date
- Nov 13, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$2.64
- EPS Surprise
- 46.52%
- Revenue Surprise
- 29.55%
Beat Rate
Last 8 Quarters 25%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -2.64 | -4.94 | 46.52% | 85.81% | 528.56K | 408K | 29.55% | 291.53% |
| Q2 2025 | -5.00 | -3.92 | -27.66% | 94.09% | 307.87K | 307.02K | 0.28% | 146.30% |
| Q1 2025 | -6.24 | -5.37 | -16.31% | -186.67% | 163K | 231.54K | -29.60% | 11.58% |
| Q4 2024 | -56.80 | -16.36 | -247.17% | 34.26% | 231K | 238.68K | -3.22% | 440.86% |
| Q3 2024 | -18.60 | -14.38 | -29.33% | -110.06% | 135K | 246.84K | -45.31% | 164.71% |
| Q2 2024 | -84.60 | -57.02 | -48.37% | - | 125K | 215.73K | -42.06% | 99.36% |
| Q1 2024 | 7.20 | -36.72 | 119.61% | - | 146.09K | 164.22K | -11.04% | 579.49% |
| Q4 2023 | -86.40 | -50.18 | -72.17% | - | 42.71K | 76.5K | -44.17% | -91.65% |
| Q3 2023 | 184.80 | 232.56 | -20.54% | - | 51K | 89.25K | -42.86% | -90.87% |
| Q2 2023 | - | - | 62.7K | - | - | |||
| Q1 2023 | - | - | 21.5K | - | - | |||
| Q4 2022 | - | - | 511.2K | - | - | |||
| Q3 2022 | - | - | 558.5K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-61.15%
Max EPS beat (4)
46.52%
Min EPS beat (4)
-247.17%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-0.75%
Max Revenue beat (4)
29.55%
Min Revenue beat (4)
-29.60%
Analysis
In the last 4 quarters, SXTP has beaten EPS estimates in 1 out of 4 releases
SXTP has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, SXTP reported -61.2% below the EPS estimates on average.
In the last 4 quarters, SXTP reported -0.7% below the revenue estimates on average.
Related analysis
60 DEGREES PHARMA INC / SXTP Earnings FAQ
Did SXTP stock beat earnings estimates in the most recent quarter?
60 DEGREES PHARMA INC (SXTP) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does 60 DEGREES PHARMA INC (SXTP) beat earnings estimates?
In the last 4 quarters, 60 DEGREES PHARMA INC (SXTP) has beaten EPS estimates in 1 out of 4 releases.